Featured
Another October listing as Govt rushes to beat deadline
A harried Government has announced politically urgent PBS funding for a drug to replace one that is being pulled from the Scheme in November, following a patient backlash
Featured
Pharma skyrockets up World's Best Companies list
After placing 43rd last year this pharma has blasted up the rankings to be named the world's fifth best company, trouncing industry rivals
Leadership & People
Who's given Mark Butler an award?
Politicians are more likely cop flak than awards but the Health Minister has won a prestigious gong for his significant contribution to public health
Regulatory & Reimbursement
PBAC to PBS: the fastest-moving submissions
Two months on from the PBAC's July meeting, just over 60 per cent of the submissions recommended have started progressing towards a PBS listing
Regulatory & Reimbursement
People are dying, where's the access?
A LifeSciences Australia Summit has been told that HTA reforms which the Govt has been sitting on for more than five years are already out of date
Regulation & Legal
A decade on, judge rules biosimilar not infringing
After almost 10 years of legal wrangling over what has become the highest earning biosimilar referencing this one-time blockbuster, a loss for this Big Pharma
Featured
Significant job cuts hit pharma, with ANZ GM let go
ANZ General Manager among those being let go as “overlapping roles” are made redundant following a recent buyout
Featured
Who's been named a top employer?
Judged on leadership, engagement, communication and employee benefits this Big Pharma has taken home a prestigious Australian HR award
Industry & Companies
Second pharma joins Medicines Australia
Another company has joined Medicines Australia as a Class 1 Member this month, with its ANZ chief revealing why it is a pivotal time for industry to speak up
Industry & Companies
$50K research prize up for grabs
Eight finalists tackling some of the most pressing challenges in health and medicine are in the running for funding to boost their research
Jobs & Workplace
Ex-Aussie GM wins global promotion
Less than two years after leaving Australia, this former long-time ANZ GM has already won another promotion, stepping into an important role
Regulation & Legal
'Faster acting' claim lands in Federal Court
A series of ads claiming superiority over a competitor has ruffled feathers, with the companies landing in court despite agreeing to mediation
Industry & Companies
Sanofi exposes critical ‘GP gap’ in Australia
New data being presented by two Sanofi staffers shows that GPs hold the key to unlocking both clinical trial participation and representation across Australia
Industry & Companies
Fertility a workplace issue: Merck survey
Nearly two in three young Australians believe employers should provide greater workplace support for people navigating fertility issues
Featured
Which Big Pharma is changing its name?
One of the world's best known pharmaceutical companies is reportedly changing its name and introducing a new slogan
Jobs
Industry & Companies
Why Australia can't win against Trump's MFN policy
New number-crunching has revealed that accepting Australia's notoriously low pricing for a medicine would cost a company more than an entire year's worth of local sales for that drug
Industry & Companies
'The Novo Way' marks a new way of working
The company has updated its culture sharpening how it competes, works and delivers in a faster, more competitive market and there's more to come
Latest
Doctors feel the fear but do it anyway
Survey of Aussie GPs finds accuracy and hallucination risk is considered a "major concern" when it comes to AI yet eight in 10 are using it anyway
Latest
Never heard of it: disease gap exposed
Pharma commissioned survey reveals low awareness about this chronic disease with symptoms often mistaken as stress associated with 'everyday living'
Regulatory & Reimbursement
Telix lands an FDA three-peat
Meeting a significant unmet need, this approval will provide broad access to a brain imaging product already recognised in international clinical guidelines
Regulation & Legal
Fake Lilly drug causes serious side effect
An Australian patient suffered a torn oesophagus after using the counterfeit, which contained eight times the active ingredient used in a popular drug, sponsored by a rival company
Leadership & People
GM ANZ role up for grabs
Pharma launches a recruitment drive to find the company's next leader with a glowing reference from its departing GM
Leadership & People
Is Medical Affairs the 'Jan Brady' of pharma?
The MAPA Medical Affairs Summit was told MA is like the 'middle child' of pharma in a robust debate about how best the function can unleash its true potential
- Regulatory & Reimbursement $113M Novartis drug under threat
- Other News Leaders gather for first-ever roundtable
- Other News Funding for CAR-T trials for Aussie kids
- Leadership & People Another Country Boss departs
- Regulatory & Reimbursement Who's won an October PBS listing... already?
- Leadership & People Scientists behind Big Pharma drugs gonged
- Leadership & People How to lead without the job title
- Leadership & People Meet ANZ's best Medical Affairs professionals
- Other News US Govt funds access to Aussie drug
- Industry & Companies Company eyes ‘golden decade’
